TCOT
CRDF icon

Trust Company of Toledo’s Cardiff Oncology CRDF Stock Holding History

Trust Company of Toledo’s Portfolio CRDF Stock Details CRDF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11.7K Hold
9,000
– – ﹤0.01% 677
2026
Q1 		$14.6K Buy
+9,000
New +$18.5K ﹤0.01% 607

Other funds holding CRDF

AC
Avestar Capital New York $1.79B AUM 33.8% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
CWP
Curated Wealth Partners El Segundo, California $774M AUM 5.71% 1-Year Est. Return
PRTG
Post Resch Tallon Group Pittsford, New York $145M AUM 25.19% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
PI
PFG Investments Woodbury, New York $2.58B AUM 36.93% 1-Year Est. Return
BEAM
Baker Ellis Asset Management Vancouver, Washington $964M AUM 39.24% 1-Year Est. Return
CAWM
Capital Advisors Wealth Management Yakima, Washington $851M AUM 22.16% 1-Year Est. Return
GIA
Gladstone Institutional Advisory Palm Beach Gardens, Florida $3.16B AUM 29.04% 1-Year Est. Return
SA
Scarborough Advisors Annapolis, Maryland $871M AUM 21.96% 1-Year Est. Return

Trust Company of Toledo's CRDF Position: Q2 2026 in Review

Trust Company of Toledo held its Cardiff Oncology (CRDF) position steady in Q2 2026 at 9,000 shares worth $11.7K. The position accounts for ﹤0.01% of the portfolio, ranked #677.

Trust Company of Toledo first reported a position in CRDF in Q1 2026 and has held it in 2 quarters since. The position peaked at $14.6K in Q1 2026. 22 funds tracked by Wall St. Rank hold CRDF as of Q2 2026.

  • Trust Company of Toledo held 9,000 shares of Cardiff Oncology worth $11.7K as of Q2 2026.
  • Trust Company of Toledo left its Cardiff Oncology share count unchanged in Q2 2026.
  • Cardiff Oncology made up ﹤0.01% of Trust Company of Toledo's portfolio in Q2 2026, its #677 holding.
  • Trust Company of Toledo first reported a position in Cardiff Oncology in Q1 2026 and has held it in 2 quarters since.
  • Trust Company of Toledo's Cardiff Oncology position peaked at $14.6K in Q1 2026.
  • 22 funds tracked by Wall St. Rank held Cardiff Oncology as of Q2 2026.

Based on Trust Company of Toledo's 13F filing for Q2 2026, filed 16 Jul 2026.